UnicoCell Biomed Co., Ltd. (TPE:6794)

UnicoCell Biomed Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	46.55	40.84	9.57	19.9	53.64	130.85
Short-Term Investments	630.4	692.08	518.37	457.38	160.25	10.17
Trading Asset Securities	27.25	13.35	22.3	-	-	-
Cash & Short-Term Investments	704.2	746.27	550.24	477.28	213.89	141.02
Cash Growth	15.09%	35.63%	15.29%	123.15%	51.67%	-39.24%
Accounts Receivable	2.2	3.19	2.81	2.08	1.38	0.4
Other Receivables	19.08	19.37	19.6	18.08	13.47	12.02
Receivables	21.28	22.55	22.41	20.16	14.84	12.42
Inventory	9.2	9.27	9.75	7.5	7.98	7.83
Prepaid Expenses	2.63	3.31	3.66	1.61	1.13	2.04
Other Current Assets	6.66	5.75	6.29	0.24	0.06	-
Total Current Assets	743.98	787.16	592.35	506.8	237.9	163.31
Property, Plant & Equipment	130.04	138.04	152.59	175.89	173.36	131.21
Long-Term Investments	17.26	17.26	29	-	-	-
Other Intangible Assets	0.11	0.26	0.34	0.33	0.36	0.4
Other Long-Term Assets	4.09	3.29	3.61	2.92	2.7	2.8
Total Assets	895.47	946.01	777.89	685.93	414.31	297.71

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.13	1.23	1.97	0.11	0.91	0.08
Current Portion of Leases	6.41	6.35	6.22	6.09	5.93	8.95
Current Unearned Revenue	1.17	1.1	6.62	0.02	1.52	-
Other Current Liabilities	12.49	12.06	12.32	10.68	8.18	12.34
Total Current Liabilities	20.21	20.73	27.13	16.9	16.54	21.37
Long-Term Leases	52.45	55.67	62.02	68.24	60.66	12.63
Other Long-Term Liabilities	4.18	4.18	4.13	4.35	3.26	0.71
Total Liabilities	76.83	80.58	93.28	89.49	80.46	34.71

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	636.37	636.37	584.11	556.85	423.61	377.75
Additional Paid-In Capital	962.33	961.01	705.87	551.89	338.43	222.29
Retained Earnings	-768.33	-720.2	-605.37	-512.29	-428.19	-337.03
Comprehensive Income & Other	-11.74	-11.74	-	-	-	-
Shareholders' Equity	818.63	865.44	684.61	596.44	333.85	263.01
Total Liabilities & Equity	895.47	946.01	777.89	685.93	414.31	297.71

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	58.86	62.02	68.24	74.33	66.59	21.58
Net Cash (Debt)	645.34	684.25	482.01	402.95	147.3	119.44
Net Cash Growth	18.03%	41.96%	19.62%	173.56%	23.32%	-39.71%
Net Cash Per Share	10.28	11.24	8.40	7.49	3.55	3.17
Filing Date Shares Outstanding	63.64	63.64	58.41	55.69	42.36	37.78
Total Common Shares Outstanding	63.64	63.64	58.41	55.69	42.36	37.78
Working Capital	723.77	766.43	565.22	489.9	221.36	141.94
Book Value Per Share	12.86	13.60	11.72	10.71	7.88	6.96
Tangible Book Value	818.53	865.18	684.27	596.12	333.5	262.61
Tangible Book Value Per Share	12.86	13.60	11.71	10.71	7.87	6.95
Machinery	72.32	73.95	70	67.02	65.56	60.92
Construction In Progress	-	-	-	-	-	68.3
Leasehold Improvements	99.39	99.39	98.28	97.5	93.25	16.35

Data Source: S&P Global Market Intelligence Last updated: Aug 12, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 5, 2026

Data Sources Report a data error